Providers can immediately resume vaccinating patients for COVID-19 using Johnson & Johnson’s single-dose shot after federal officials recommended a pause due to a rare blood clotting disorder.
Providers can immediately resume vaccinating patients for COVID-19 using Johnson & Johnson’s single-dose shot after federal officials recommended a pause due to a rare blood clotting disorder.